185
Views
5
CrossRef citations to date
0
Altmetric
INNER EAR

Adeno-associated viral vector-mediated expression of NT4-ADNF-9 fusion gene protects against aminoglycoside-induced auditory hair cell loss in vitro

, , , &
Pages 136-141 | Received 09 Jun 2010, Accepted 09 Aug 2010, Published online: 09 Nov 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Guoxi Zheng, Zhu Zhu, Kang Zhu, Junrong Wei, Yang Jing & Maoli Duan. (2013) Therapeutic effect of adeno-associated virus (AAV)-mediated ADNF-9 expression on cochlea of kanamycin-deafened guinea pigs. Acta Oto-Laryngologica 133:10, pages 1022-1029.
Read now

Articles from other publishers (4)

Mary P. Lee & Joerg Waldhaus. (2022) In vitro and in vivo models: What have we learnt about inner ear regeneration and treatment for hearing loss?. Molecular and Cellular Neuroscience 120, pages 103736.
Crossref
Xian-Cang Ma, Zheng Chu, Xiao-Ling Zhang, Wen-Hui Jiang, Min Jia, Yong-Hui Dang & Cheng-Ge Gao. (2016) Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect. Neurochemical Research 41:6, pages 1375-1380.
Crossref
Jochen Schacht & Michael G. Leitner. 2014. In Vitro Toxicology Systems. In Vitro Toxicology Systems 199 222 .
Lawrence R. Lustig & Omar Akil. (2012) Cochlear gene therapy. Current Opinion in Neurology 25:1, pages 57-60.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.